Related Experiment Videos
[Endoscopic extraperitoneal radical prostatectomy. Results after 300 procedures]
J-U Stolzenburg1, M C Truss, R Rabenalt
1Klinik und Poliklinik für Urologie, Universitätsklinikum Leipzig. stolj@medizin.uni-leipzig.de
Der Urologe. Ausg. A
|April 7, 2004
Summary
Endoscopic extraperitoneal radical prostatectomy (EERPE) offers a minimally invasive approach for prostate cancer, achieving favorable short-term oncological and functional outcomes. This technique provides advantages over traditional laparoscopic radical prostatectomy (LRPE) with reduced operative times and lower complication rates.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Laparoscopic radical prostatectomy (LRPE) is a standard technique for localized prostate cancer but involves transperitoneal access with potential complications.
- Endoscopic extraperitoneal radical prostatectomy (EERPE) offers a strictly extraperitoneal approach, aiming to overcome LRPE limitations.
Purpose of the Study:
- To introduce technical modifications and refinements for EERPE, including a nerve-sparing, potency-preserving approach (nEERPE).
- To report short-term follow-up results after 300 EERPE procedures.
Main Methods:
- 300 EERPE procedures were performed with a focus on technical improvements and a nerve-sparing approach.
- Data collected included operative times, conversion rates, transfusion rates, reinterventions, pathological staging, surgical margins, catheterization duration, and postoperative continence rates.
Main Results:
- Mean operative time was 140 minutes; no conversions were required, and the transfusion rate was 1.3%.
- Early and late reintervention rates were low (2.7% and 1.7%, respectively).
- Postoperative continence rates at 6 and 12 months were high (86.3% and 89.6% completely continent).
Conclusions:
- EERPE demonstrates short-term oncological and functional results comparable to LRPE.
- EERPE offers shorter operative times and low complication rates, representing a technical advancement in minimally invasive prostate cancer surgery.